Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chengdu Aobang Pharmaceutical is a China-based pharmaceutical company focused on the research, development, and large-scale production of chemical drug products. The company specializes in several key therapeutic areas, including cardiovascular health, gastroenterology, and anti-infectives. Its commercial portfolio includes widely recognized generic medications such as amlodipine besylate for hypertension and rabeprazole sodium for gastric disorders. Operating out of Chengdu, Sichuan, the company maintains GMP-certified manufacturing facilities to ensure high-quality standards for the domestic market. Chengdu Aobang Pharmaceutical is recognized as a high-tech enterprise in China, emphasizing the modernization of traditional chemical synthesis and drug formulation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengdu Aobang Pharmaceutical.